(2-(trimethylammonium)ethyl)methanethiosulfonate has been researched along with rhodamine b in 1 studies
Studies ((2-(trimethylammonium)ethyl)methanethiosulfonate) | Trials ((2-(trimethylammonium)ethyl)methanethiosulfonate) | Recent Studies (post-2010) ((2-(trimethylammonium)ethyl)methanethiosulfonate) | Studies (rhodamine b) | Trials (rhodamine b) | Recent Studies (post-2010) (rhodamine b) |
---|---|---|---|---|---|
143 | 0 | 17 | 1,758 | 15 | 1,198 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bartlett, MC; Clarke, DM; Loo, TW | 1 |
1 other study(ies) available for (2-(trimethylammonium)ethyl)methanethiosulfonate and rhodamine b
Article | Year |
---|---|
The drug-binding pocket of the human multidrug resistance P-glycoprotein is accessible to the aqueous medium.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Biological Transport; Buffers; Cell Line; Colchicine; Cyclosporine; Cysteine; Drug Resistance, Multiple; Gene Expression Regulation; Humans; Hydrolysis; Isoleucine; Mesylates; Mutation; Rhodamines; Verapamil; Water | 2004 |